Streetbeat News

Stock Prices

FTK

Flotek Industries has raised its 2024 adjusted EBITDA guidance range from $10 million-$16 million to $14 million-$18 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:24 pm

GNL

Global Net Lease (GNL) has raised its 2024 closed disposition guidance from $400 million - $600 million to $650 million - $800 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:24 pm

CYRX

CryoPort (NASDAQ:CYRX) reported Q2 2024 adjusted EPS of $(0.29), beating the analyst estimate of $(0.39) by 25.64%. However, sales of $57.597 million slightly missed the estimate of $57.684 million by 0.15%. Sales increased by 1.01% compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:24 pm

HNRG

Hallador Energy (NASDAQ:HNRG) reported Q2 2024 GAAP EPS of $(0.27), missing the $(0.11) estimate by 145.45%. Sales were $90.914M, missing the $108.000M estimate by 15.82% and down 43.60% from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:22 pm

AERT

Aeries Technology, Inc. (NASDAQ:AERT) received a deficiency notification from Nasdaq due to a delayed filing of its Annual Report on Form 10-K for the fiscal year ended March 31, 2024. The company is not in compliance with Nasdaq Listing Rule 5250(c)(1).

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:22 pm

CTKB

Cytek Biosciences has revised its FY24 revenue outlook to $203M-$210M from the previous $203M-$213M, with an estimated $208.801M. The company now expects to report a net loss in the single-digit millions for FY24, instead of a positive net income, due to slightly lower gross profit, higher stock-based compensation, and lower other income. However, Cytek anticipates generating positive cash flow from operations in 2024.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:21 pm

GNSS

Genasys shares are trading higher after the company reported better-than-expected Q3 sales results.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:20 pm

RIGL

Rigel Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:20 pm

GNSS

Genasys (NASDAQ:GNSS) reported Q3 EPS of $(0.15), meeting analyst estimates, and sales of $7.17M, beating the $6.93M estimate. However, both EPS and sales showed significant declines compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:20 pm

CLLS

Cellectis (NASDAQ:CLLS) reported a Q2 2024 adjusted EPS of $(0.24), beating the analyst consensus estimate of $(0.30) by 20%.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:19 pm